Omega Therapeutics, Inc. Common Stock (OMGA)

OMGA was delisted on the 24th of February, 2025.

• Market cap: $7.9M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.

Employees: 94